Get Connected:

Medical News

Daily news and information for physicians in a range of specialties and practice settings.

Latest Medical News

Using Roseroot to Improve Major Depressive Disorder Symptoms
Using Roseroot to Improve Major Depressive Disorder Symptoms
Rhodiola rosea (R. rosea), also known as roseroot, may be an effective antidepressant that is safer and better tolerated than sertraline.
AbbVie Gets Japanese approval for Hepatitis C Drug
Japanese regulators have approved AbbVie's Viekirax to treat patients with genotype 1 chronic hepatitis C, including those with compensated cirrhosis, the most common type of hepatitis in that country.
10 States with the Highest Rates of Injury-Related Deaths
Injuries are the leading cause of death for people ages 1 to 44, and injury-related deaths are on the rise in 17 of the nation’s 50 states. These 10 states reported the highest rates of injury-related deaths.
FDA Approves New Treatment for Schizophrenia
Aristada (aripiprazole lauroxil) extended-release injectable suspension for the treatment of schizophrenia features once-monthly and six-week dosing options.
The Formula for Physicians Investing in Real Estate
What are the first few things that physicians should consider before they invest in real estate?
Beauty School Drop Out
What if doctors' offices were run like beauty salons? There could be many benefits for both patients and physicians.
Simple But Good Advice
A few simple tips can go a long way toward keeping you in good health. The same is true for your financial health.

Product News

Hypertension Combo Treatment Approved
Hypertension Combo Treatment Approved
The US Food and Drug Administration today approved combining ambrisentan (Letairis/Gilead) with tadalafil to treat pulmonary arterial hypertension.
New Stent Approved
The FDA approved a new bioabsorbable polymer drug-eluting stent system for coronary artery disease.
FDA Approves Diabetes Drugs
The FDA today approved two new diabetes drugs. The agency gave the nod to insulin degludec injection (Tresiba/Novo Nordisk) and insulin degludec/insulin aspart (Ryzodeg/Novo Nordisk)
Drug for Schizophrenia, Bipolar Disorder Gets FDA Approval
The FDA approved cariprazine (Vraylar/Forest Labs) for treating schizophrenia and bipolar disorder in adults.
New Indication for Adalimumab
Adalimumab gets new indication for hidradenitis suppurativa.
Swab Test for Genital Herpes Approved
The US Food and Drug Administration today announced it will permit Quest Diagnostics' Focus Diagnostics division to market a genital swab test for herpes simplex virus type 2.

Most Popular

$vacMongoViewPlus$ $vAR$